| Title |
Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
|
|---|---|
| Published in |
Journal of the Egyptian National Cancer Institute, March 2020
|
| DOI | 10.1186/s43046-020-00025-5 |
| Pubmed ID | |
| Authors |
Salah Fayaz, Heba El-Sayed Eissa, Gerges Attia Demian |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 3 | 13% |
| Unspecified | 2 | 9% |
| Student > Master | 2 | 9% |
| Student > Ph. D. Student | 2 | 9% |
| Student > Doctoral Student | 1 | 4% |
| Other | 6 | 26% |
| Unknown | 7 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 30% |
| Unspecified | 2 | 9% |
| Nursing and Health Professions | 2 | 9% |
| Agricultural and Biological Sciences | 2 | 9% |
| Social Sciences | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 8 | 35% |